Media headlines about Intermolecular (NASDAQ:IMI) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intermolecular earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the semiconductor company an impact score of 45.394500039978 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Intermolecular (IMI) traded up 2.83% on Friday, reaching $1.09. 11,018 shares of the company’s stock traded hands. The company has a 50 day moving average of $0.95 and a 200-day moving average of $0.92. Intermolecular has a 52 week low of $0.78 and a 52 week high of $1.20. The stock’s market capitalization is $54.02 million.
Separately, ValuEngine raised shares of Intermolecular from a “strong sell” rating to a “sell” rating in a research report on Monday, August 7th.
TRADEMARK VIOLATION NOTICE: “Intermolecular (IMI) Given News Sentiment Score of 0.10” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://transcriptdaily.com/2017/10/08/intermolecular-imi-given-news-sentiment-score-of-0-10.html.
In other Intermolecular news, major shareholder Lloyd I. Miller III bought 34,109 shares of the company’s stock in a transaction on Friday, September 1st. The shares were bought at an average cost of $0.86 per share, with a total value of $29,333.74. Following the completion of the acquisition, the insider now owns 70,368 shares of the company’s stock, valued at $60,516.48. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have acquired 38,930 shares of company stock worth $33,480 over the last three months. 45.40% of the stock is owned by corporate insiders.
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.